Dried Aluminium Hydroxide Gel Market Size, Share & Forecast Report - 2026 to 2030

The dried aluminium hydroxide gel market size was valued at over USD 0.7 billion in 2024 and anticipated to register a significant CAGR of 3.5% over the forecast period 2025 to 2030. The rising prevalence of gastric acidity and indigestion worldwide primarily drives the dried aluminium hydroxide gels market growth. Furthermore, the growing incidence of hyperphosphatemia in patients suffering from the renal disease will further accentuate the dried aluminium hydroxide gels market growth.

Dried aluminium hydroxide gels is also popularly known as aluminium hydroxide gels, it is either used alone or in combination with magnesium hydroxide and simithecone for the treatment of acidity. It needs to be taken judiciously in order to prevent the occurrence of side effects such as constipation, rash itching etc. It is important to understand that while taking aluminium hydroxide enriched drug molecule the consumer should avoid intake of food rich in citrate as it may increase the absorption of aluminium and cause severe toxicity.

Market Outlook:

To know more about the study, request a report sample

Dried Aluminium Hydroxide Gel Market Driving Factors:

A major driving factor for the dried aluminium hydroxide gel market is the rising prevalence of gastrointestinal disorders, such as acid reflux, gastritis, and peptic ulcers. Dried aluminium hydroxide gel is widely used as an active ingredient in antacid formulations due to its ability to neutralize excess stomach acid and provide quick relief. With changing dietary habits, increasing stress levels, and rising consumption of processed foods, the incidence of gastrointestinal conditions is growing globally, thereby fueling demand for antacids and supporting the growth of the dried aluminium hydroxide gel market.

Another key driver is the growing use of dried aluminium hydroxide gel in pharmaceuticals and other industries. Apart from its role in antacids, it is also used as an adjuvant in vaccines, enhancing immune response and improving vaccine efficacy. The increasing number of vaccination programs worldwide, along with ongoing research into new vaccines, is boosting its demand. Additionally, its applications in cosmetics, personal care, and other formulations are creating steady growth opportunities. Expanding healthcare infrastructure in emerging economies and rising awareness of preventive healthcare further strengthen market demand.

Industry Trends Shaping the Dried Aluminium Hydroxide Gel Market:

One of the key trends in the dried aluminium hydroxide gel market is the increasing innovation in antacid formulations. Pharmaceutical companies are developing combination therapies that pair aluminium hydroxide gel with other active ingredients such as magnesium hydroxide, simethicone, or alginates to improve effectiveness and minimize side effects like constipation. These advanced formulations are gaining popularity in both over-the-counter (OTC) and prescription markets, particularly as consumers demand faster relief and more comprehensive gastrointestinal care. Additionally, the rising preference for chewable tablets, flavored suspensions, and easy-to-administer formats is shaping product development trends.

Another important trend is the growing demand for aluminium hydroxide gel as a vaccine adjuvant. With global vaccination programs expanding, especially after the COVID-19 pandemic, demand for reliable adjuvants to enhance immune response has increased. Aluminium-based adjuvants remain the gold standard in many vaccines, and continued research into new vaccine development, including those for cancer, infectious diseases, and allergies, is strengthening their market relevance. At the same time, regulatory authorities are emphasizing the safety and quality of adjuvants, pushing manufacturers to adopt advanced purification and production techniques, thereby driving innovation in the dried aluminium hydroxide gel market.

Dried Aluminium Hydroxide Gel Market Opportunities:

The dried aluminium hydroxide gel market presents significant opportunities in the expanding pharmaceutical and vaccine industries. Its critical role as an adjuvant in vaccines provides a long-term growth pathway, especially with ongoing global efforts to develop vaccines for emerging infectious diseases and chronic conditions such as cancer. Governments and international health organizations continue to invest heavily in vaccination programs, creating consistent demand for aluminium-based adjuvants. Pharmaceutical companies that focus on improving the purity, stability, and efficacy of dried aluminium hydroxide gel can strengthen their position in this evolving space.

Another opportunity lies in the increasing demand for OTC gastrointestinal treatments and product diversification. With the rising prevalence of lifestyle-related digestive disorders, consumers are increasingly turning to convenient and effective antacid solutions. Manufacturers can capitalize on this trend by offering innovative formulations such as flavored suspensions, chewable tablets, and combination therapies that enhance consumer appeal. Furthermore, expanding into emerging markets where awareness of digestive health is growing, supported by rising healthcare access and affordability, presents untapped potential for market expansion.

Market Segments Insights:

Antacid is representing the largest market share in the clinical application segment for dried aluminium hydroxide gels market. It is a very popular inorganic salt which is prescribed as an antacid by physicians worldwide. It is basic in nature and is beneficial in neutralizing the hydrochloric acid produced in gastric secretions, hence subsequent increase in the pH inhibits the action of pepsin and simultaneous increase in the levels of bicarbonate ions and prostaglandins ensure cytoprotective effects. Hyperphosphatemia is keen to register impressive market growth on account of the increasing formulation and development activities conducted in pharmaceutical industries in adjusting the dose of dried aluminium hydroxide gels for the treatment of hyperphosphatemia in patients suffering with chronic kidney disease.

Hospital pharmacy is presently reigning the distribution channel segment for dried aluminium hydroxide gels market. Precise compounding by hospital pharmacist in mandatory while dispensing medicines for patients suffering with hyperphosphatemia due to chronic kidney disease. Retail pharmacy is expected to register comfortable market growth owing to the constant surge observed in the over the counter (OTC) products and generic drugs market in the developing regions.

Global dried aluminium hydroxide gels market size and forecast were obtained by using “Bottom-up” and “Top-down” approaches. Extensive secondary research was conducted to understand the market insights and trends, followed by primary interviews to further validate the information sourced. The report provides both, qualitative and quantitative analyses of the market, the competitive landscape, and the preferred development strategies of key players which help to formulate competitive market strategies and make informed decisions.

Dried Aluminium Hydroxide Gel Market Segmentation:

By Clinical Application:

• Antacid
• Hyperphosphatemia
• Others

By Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage: North America Holds the Largest Share of Dried Aluminium Hydroxide Gel Market

North America is currently leading the geography segment for the dried aluminum hydroxide gels market. The rising prevalence of gastric acidity primarily drives the market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 30% of the United States population is suffering from gastric acidity. Increasing consumption of alcohol, craving for fast food, obesity are the major causative factors responsible for the occurrence of gastric acidity in the region. Affordable reimbursement scenario for the dried aluminum hydroxide gels drugs formulation further accelerates the market growth in the region. Europe is placed 2^nd in the regional segment on account of the strategic partnership between research academia and pharmaceutical companies to determine the dosage regimen of dried aluminum hydroxide gels in the treatment of hyperphosphatemia in patients suffering from chronic kidney disease. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of the flourishing over the counter (OTC) products market and emergence of local players.

Market Competition Assessment:

Key players operating in the global dried aluminium hydroxide gels market are Kyowa Chemical Industry, Walgreen Company, Merck KGaA, Sanofi-Aventis, and Johnson & Johnson. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Kyowa Chemical Industry
• SPI Pharma
• Walgreen Company
• Merck KGaA
• Sanofi-Aventis
• Johnson & Johnson
• Teva Pharmaceutical Industries Ltd.
• Cadila Healthcare Ltd
• Mylan Seiyaku
• Sun Pharmaceuticals Ltd.

Key Questions Answered by Dried Aluminium Hydroxide Gels Market Report:

• Global dried aluminium hydroxide gels market forecasts from 2025-2030
• Regional dried aluminium hydroxide gels market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
• Country-level forecasts from 2025-2030 covering 15 major countries from the aforementioned regions
• Dried aluminium hydroxide gels submarket forecasts from 2025-2030 covering the market by clinical application, by distribution channel, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis pertaining to market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2025-2030
• Competitive Landscape and market positioning of top 10 players operating in the market